Literature DB >> 31369432

T and B lymphocytes in fibrosis and systemic sclerosis.

Shiv Pillai1.   

Abstract

PURPOSE OF REVIEW: To summarize recent advances in the understanding of the pathogenesis of autoimmune fibrotic diseases. These diseases include IgG4-related disease, systemic sclerosis and lupus nephritis. RECENT
FINDINGS: Recent studies indicate that a poorly studied subset of helper T cells, cytotoxic CD4+ T cells and sub-populations of disease-specific activated B cells infiltrate inflamed tissues and collaborate to induce tissue fibrosis in autoimmune fibrotic diseases. Cycles of apoptosis induced by antigen-specific cytotoxic CD4+ T cells followed by macrophage-mediated clearing of apoptotic cells and finally tissue remodeling driven by cytokines released by these auto-antigen-specific activated T and B cells may contribute to the activation of fibroblasts and myofibroblasts and the laying down of collagen. In scleroderma, this process likely involves the apoptosis of endothelial cells and other neighboring cells and the subsequent remodeling of the tissue.
SUMMARY: Self-reactive cytotoxic CD4+ T cells infiltrate tissues where they may be nurtured by activated auto-reactive B cells, induce apoptosis, secrete cytokines and thus drive autoimmune fibrosis.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31369432     DOI: 10.1097/BOR.0000000000000644

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  9 in total

1.  Effect of crosstalk between Th17 and Th9 cells on the activation of dermal vascular smooth muscle cells in systemic scleroderma and regulation of tanshinone IIA.

Authors:  Mengguo Liu
Journal:  An Bras Dermatol       Date:  2022-09-15       Impact factor: 2.113

Review 2.  Foreign body response to synthetic polymer biomaterials and the role of adaptive immunity.

Authors:  Themis R Kyriakides; Hyun-Je Kim; Christy Zheng; Lauren Harkins; Wanyun Tao; Emily Deschenes
Journal:  Biomed Mater       Date:  2022-03-04       Impact factor: 4.103

3.  CD4+CTLs in Fibrosing Mediastinitis Linked to Histoplasma capsulatum.

Authors:  Hugues Allard-Chamard; Faisal Alsufyani; Naoki Kaneko; Kelly Xing; Cory Perugino; Vinay S Mahajan; Joseph L Wheat; George S Deepe; James Loyd; Shiv Pillai
Journal:  J Immunol       Date:  2020-12-16       Impact factor: 5.422

Review 4.  Exosomes in Systemic Sclerosis: Messengers Between Immune, Vascular and Fibrotic Components?

Authors:  Marta Colletti; Angela Galardi; Maria De Santis; Giacomo Maria Guidelli; Angela Di Giannatale; Luigi Di Luigi; Cristina Antinozzi
Journal:  Int J Mol Sci       Date:  2019-09-04       Impact factor: 5.923

5.  Congruent microbiome signatures in fibrosis-prone autoimmune diseases: IgG4-related disease and systemic sclerosis.

Authors:  Damian R Plichta; Juhi Somani; Matthieu Pichaud; Zachary S Wallace; Ana D Fernandes; Cory A Perugino; Harri Lähdesmäki; John H Stone; Hera Vlamakis; Daniel C Chung; Dinesh Khanna; Shiv Pillai; Ramnik J Xavier
Journal:  Genome Med       Date:  2021-02-28       Impact factor: 11.117

6.  Elevated soluble CD163 predicts renal function deterioration in lupus nephritis: a cohort study in Eastern China.

Authors:  Guangxia Yang; Naifeng Guo; Jun Yin; Jianhua Wu
Journal:  J Int Med Res       Date:  2021-11       Impact factor: 1.671

7.  IL-13 and IL-33 Serum Levels Are Increased in Systemic Sclerosis Patients With Interstitial Lung Disease.

Authors:  Antonio Giovanni Versace; Alessandra Bitto; Carmelo Ioppolo; Caterina Oriana Aragona; Daniela La Rosa; William Neal Roberts; Tommaso D'Angelo; Antonella Cinquegrani; Santa Cirmi; Natasha Irrera; Michele Navarra; Salvatore Corrao; Sebastiano Gangemi; Gianluca Bagnato
Journal:  Front Med (Lausanne)       Date:  2022-02-17

Review 8.  IgG4 Autoantibodies in Organ-Specific Autoimmunopathies: Reviewing Class Switching, Antibody-Producing Cells, and Specific Immunotherapies.

Authors:  Inga Koneczny; John Tzartos; Marina Mané-Damas; Vuslat Yilmaz; Maartje G Huijbers; Konstantinos Lazaridis; Romana Höftberger; Erdem Tüzün; Pilar Martinez-Martinez; Socrates Tzartos; Frank Leypoldt
Journal:  Front Immunol       Date:  2022-03-24       Impact factor: 7.561

Review 9.  Idiopathic pulmonary fibrosis and systemic sclerosis: pathogenic mechanisms and therapeutic interventions.

Authors:  Hamid Mattoo; Shiv Pillai
Journal:  Cell Mol Life Sci       Date:  2021-06-18       Impact factor: 9.261

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.